Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Jun 13;3(6):e0001344. doi: 10.1371/journal.pgph.0001344

Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda

James Muleme 1,2,*, David Musoke 1, Bonny E Balugaba 1, Stevens Kisaka 2,3, Frederick E Makumbi 3, Esther Buregyeya 1, John Bosco Isunju 1, Rogers Wambi 2,4, Richard K Mugambe 1, Clovice Kankya 2, Musso Munyeme 5, John C Ssempebwa 1
Editor: Ismail Ayoade Odetokun6
PMCID: PMC10270331  PMID: 37310955

Abstract

Background

Extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-Ec) represents a significant global public health concern. The epidemiology of ESBL-Ec in Uganda is not well understood although it is harbored by humans, animals, and the environment. This study explains the epidemiology of ESBL-Ec using a one health approach in selected farming households in Wakiso district, Uganda.

Methodology

Environmental, human, and animal samples were collected from 104 households. Additional data were obtained using observation checklists and through interviews with household members using a semi-structured questionnaire. Surface swabs, soil, water, human and animal fecal samples were introduced onto ESBL chromogenic agar. The isolates were identified using biochemical tests and double-disk synergy tests. To assess associations, prevalence ratios (PRs) were computed using a generalized linear model (GLM) analysis with modified Poisson and a log link with robust standard errors in R software.

Results

Approximately 83% (86/104) households had at least one positive ESBL-Ec isolate. The overall prevalence of ESBL-Ec at the human-animal-environment interface was approximately 25.0% (95% CI: 22.7–28.3). Specifically, humans, animals and the environment had an ESBL-Ec prevalence of 35.4%, 55.4%, and 9.2% respectively. Having visitors (adj PR = 1.19, 95% CI: 1.04–1.36), utilizing veterinary services (adj PR = 1.39, 95% CI: 1.20–1.61) and using animal waste for gardening (adj PR = 1.29, 95% CI: 1.05–1.60) were positively associated with household ESBL-Ec contamination. Covering the drinking water container with a lid (adj PR = 0.84 95% CI: 0.73–0.96) was associated with absence of ESBL-Ec in a household.

Conclusion

There is wider dissemination of ESBL-Ec in the environment, humans, and animals, indicating poor infection prevention and control (IPC) measures in the area. Improved collaborative one health mitigation strategies such as safe water chain, farm biosecurity, household and facility-based IPC measures are recommended to reduce the burden of antimicrobial resistance at community level.

Introduction

If no appropriate measures are taken, it is projected that approximately 10,000,000 deaths and about US$100 trillion in economic losses will occur per year by 2050 due to antimicrobial resistance [1]. Infections caused by Extended Beta Lactamase producing Escherichia coli (ESBL-Ec) have been implicated in severe disease outbreaks globally [24]. Studies have reported that the resistance to third generation cephalosporin in E. coli ranged from 0–87% whereas resistance to fluoroquinolones ranged from 0–98%. In Tanzania, deaths due to sepsis among neonates have been attributed to ESBL infections [5]. A review by Martischang et al, in 2020, reported that the prevalence of ESBL-Ec co-carriage among household members ranged from 8% to 37% [68]. This implies that such infections are emerging “One Health” threats compromising the safety and health of humans, animals, as well as the purity of the environment globally. Even though irrational drug use has been implicated as an internationally recognized cause of intrinsic antimicrobial resistance (AMR) [7], the interactions and associated dynamics among humans, animals and environment are increasingly being pinned as major phenomena for the registered global AMR burden [6, 9]. To understand the dynamics of the dispersal of ESBL-Ec into natural environments beyond human and domestic animal population, it is important to keep in mind the general E. coli population as well. E. coli is ubiquitous, and asymptomatically colonizes the gut of birds and mammals.

The cause of human ESBL-Ec colonization is still contentious as different studies have recognized the role of the environment and animals in the development, spread and spillover of antimicrobial resistant pathogens (ARPs) [8, 10]. On the other hand, studies have also reported that this relationship could be ambidirectional suggesting that humans could also spread the ESBL-Ec to animals and the environment [11, 12]. In addition, the inter-species transmission has also been reported globally (i.e., human to humans and animal to animal transmission) [13]. Indeed, there is a lot of undetected community carriage and transmission of ESBL-Ec at the human-animal-environment interface [14] even though there is inadequate local evidence for this. Such insufficient evidence deters the formulation of appropriate policies, strategies, and regulations to for the control of AMR [15, 16].

Following the global call for management of AMR (WHO “tricycle protocol”), the government of Uganda developed the National Action Plan (NAP) for AMR to protect human, animal, and environmental health [17]. This plan identifies a critical information gap regarding AMR especially at the Human-animal-environment interface. In areas like Wakiso district, an urban farming area with a high level of antimicrobial agent use, AMR is not uncommon [18]. Coupled with having many livestock and humans, it presents a high opportunity for human-animal interaction hence providing a good platform to study ESBL-Ec transmission dynamics. In response to the WHO “tricycle protocol” and the Uganda NAP, our study described the epidemiology of ESBL-Ec at the human-animal-environment interface in a local peri-urban farming community in Wakiso district, central Uganda.

Methods

Study design and area

We conducted a cross-sectional study within farming communities of Wakiso district (00 24N, 32 29E). Wakiso district is the most populated district in Uganda with an average household size of 5 persons [19]. It is also one of the districts with the highest livestock numbers in Uganda [19]. The district has 503,442 households, 36% of which are engaged in both crop and animal husbandry [20]. The district is estimated to have these species of livestock: cattle (114,769), goats (132,964), sheep (27,542), pigs (199,962), chicken (2,783,509), ducks (33,350) and turkeys (4,852) [21]. Out of the total land area of 280,772.3 hectares, approximately 97,166.3 hectares (34.61%) are being used for agricultural production. Such demographic dynamics create a high probability of human-animal interaction.

Sample size determination

Using Steve Bennett’s formula of cluster sample size calculation [22], 104 households were targeted as a primary unit of sampling. At each household, four human samples, 4 animal samples and 4 environmental samples were picked for uniformity making a total of 1248 samples altogether. After thorough quality checks, a total of 988 samples passed and these proceeded to the next level of laboratory analysis. Animal samples (fecal per rectal), human samples (urine and stool) and environmental samples (doorknobs, soil, animal feeding equipment and water) were picked from the same household. Each of the households was counted as a batch and all its samples (placed in small Ziploc bags) were kept in the same bigger plastic courier bag. If any of the samples there in i.e. water, urine, fecal were found uncapped, or spilt, the entire batch was canceled and the household data rejected. These rejected households were then replaced by another household in order to maintain our sample size. In addition, any samples found without matching data i.e. sample descriptions and linkage to household data, were rejected. Altogether, 260 samples did not pass these quality checks.

Study population and sampling procedure

Following a multi-stage sampling technique, our secondary sampling units (human, animal, and environment) was reached. All random sampling phases were conducted using a freely online available random number generator. Lists of villages from respective sub counties and parishes were obtained from the district veterinary office. Briefly, Wakiso district was purposively selected due to its unique presentation (see section on “Study design and area”). A total of 8 Sub counties were purposively (livestock keeping) selected with the help of a veterinary officer and from these 50% were randomly selected. From each Sub County, 50% parishes were randomly selected while villages with animals, and have had reported history of diarrhea episodes among humans were purposively selected with the help of local chairpersons and village health teams (VHTs). The households involved in the study needed to possess more than four animal species and at least two members in the household. The household was our primary sampling unit whereas humans, animals and environment comprised of the secondary sampling unit. In addition, the household also served as a unit of analysis for the associations among humans, animals, and environment as far as the epidemiology of ESBL-Ec was concerned.

Sample and data collection

A total of 104 farming households were studied between March and July 2022. Briefly, household related data, human sample donor data, environmental inspection data, and animal characteristics data were collected at each household using a mobile based application (kobo Toolbox). Pre-testing of the study tools was done among households in sub counties that were not part of this main study but within Wakiso district. A pre-tested semi-structured questionnaire was administered to household members who had experience with the key activities around the home.

A minimum of one and maximum of two individuals in a selected household were requested to provide a fecal and urine sample. A paper towel provided by the study teams and a sterile stool container with a scoop were used by each participant. Mid-stream urine was also provided by the participants during sampling. Parents always supported their children to collect the samples after a thorough consent and assent process. Additionally, animal samples were picked per rectum from a minimum of 4 animals within the sampled household. Environmental samples including soil, water for domestic use, swabs from animal feeding equipment and doorknobs were also picked. The sample containers were labelled with the unique code that represented the household and the sample category. Within four hours of sample collection, samples were delivered to the Microbiology Laboratory at the College of Veterinary Medicine Animal Resources and Biosecurity, Makerere University, in Ziploc bags under ice.

Laboratory procedures

Samples were processed as soon as they arrived in the laboratory within 4 hours of collection. We ensured this by collecting fewer samples that could easily be processed upon arrival in the laboratory. Sample processing was done by aseptically transferring sample inoculum on to freshly prepared ESBL chromogenic agar (Condalab 2062, Madrid Spain) which is used for detection of gram-negative bacteria producing extended spectrum Beta lactamase. The original samples after culture were then kept in a fridge at 4°C for reference in case any of the cultures was not successfully done.

Agar preparation and plating

Freshly prepared ESBL chromogenic agar containing ESBL supplement (condalab6042, Madrid Spain) having inhibition and selective agents was used [23]. Water and urine samples were first concentrated by centrifuging at 3000 rpm for 5 minutes prior to being introduced onto the agar. Soil samples and stool from Shoats were first emulsified/ suspended in 9mls of peptone water prior to plating. The plates were then incubated at 37°C for 24 hours at ambient humidity and air conditions. Presumptive ESBL-Ec appeared as pink, medium sized, raised, and moist colonies (Fig 1).

Fig 1. Primary cultures, upper row and sub-cultures, lower row.

Fig 1

Identification and confirmation

E. coli isolates were further confirmed by biochemical tests following manufacturer’s instructions [24]. E. coli was confirmed in case the isolate was positive for indole production, methyl red, motile, and negative for citrate utilization, urease production, and Voges-Proskauer. Those isolates with reduced susceptibility to cefotaxime (≤ 27 mm) and ceftazidime (≤ 22 mm) were confirmed for ESBLs- production using the modified double disk synergy (MDDS) method [25]. Briefly, after inoculation of the suspension onto Muller-Hinton agar (MHA), a disk of amoxicillin + clavulanic acid (20/10 μg) was placed in the center of the plate and then the disks of cefotaxime (25 μg) and ceftazidime (30 μg) were placed at 20 mm from the central disk on the same plate. The plates were then incubated at 35 °C for 24 hours and examined for an enhancement of inhibition zone of the β-lactam drugs caused by the synergy of the drugs and was interpreted as either being positive or negative for ESBLs-production (Fig 2).

Fig 2. Modified double disc diffusion test.

Fig 2

Study variables

Key independent variables for which data collected included individual demographics, household practices, animal husbandry practices, water, sanitation, and hygiene among other risk factors for occurrence of ESBL-Ec in communities. The dependent variable was the ESBL-Ec contamination status (positive or negative) of the household as defined by the status of the respective humans (carriage), animals, and the environment. The secondary dependent variable was ESBL-Ec human carriage which was defined as the presence of a positive sample i.e. either urine, or fecal or both in an individual.

Data analysis and management

All data was cleaned for any missing variables or laboratory result to have a complete dataset. A new column was added for the outcome variable (laboratory outcome for each sample i.e., positive, or negative for ESBL-Ec). This procedure was conducted for all data from the humans, animals, and those from the environment therefore this study had four datasets. All data analysis procedures were done in R version 4.2.1. Selected variables were picked from each individual dataset (human, animal, and environment) and merged to the main household dataset. Summary statistics were run, percentages and frequencies were reported in tables. Overall prevalence was defined as the total number of positive samples out of the total number of samples under consideration. Household prevalence on the other hand meant the total number of households with a positive ESBL-Ec sample out of the total number of households sampled. Bivariate and multivariate robust modified Poisson regression were performed to generate prevalence ratios (PR) and respective 95% confidence intervals.

Quality control and assurance

Trained research assistants collected all environmental samples and corresponding data. Human participants were thoroughly trained on fecal and urine sample collection before being given the sample collection containers. Upon provision of the sample from the human subject, the research assistants labelled and transported the samples while maintaining cold chain conditions. Trained veterinarians collected all animal samples during the study. All samples were verified to confirm the labeling, type, adequate volume, and integrity at the laboratory. Media quality control was also performed by inoculating standard bacterial strain of E. coli ATCC 25922 which is ESBL negative and Klebshiella Pneumoniae ATCC 700603 which is ESBL positive. The media quality control form was scored PASS in case the E. coli failed to grow and K. pneumoniae grew.

Ethical considerations

The study sought ethical approval from Makerere University School of Public Health Higher Degrees Research and Ethics Committee (SPH-2021-167) and the Uganda National Council for Science and Technology (HS1919ES). We sought permission to conduct the study from Wakiso district headquarters (Chief administrative officer and district health and veterinary offices). Assent and consent forms were issued to the participants prior to their involvement into the study. Formal written consent was obtained from the parent/guardian before any child would be involved in the study. In addition, each of the abled children provided assent after being explained to the purpose of the study and its related processes. Personal identification information such as names, phone numbers were not collected. We however used unique codes for households based on the Sub County and village. All ethical issues, and confidentiality were followed as guided by the Helsinki declaration.

Results

Characteristics of the households involved in the study

This study was conducted among 104 households from four sub counties in Wakiso district. More than 60% (65/104) of the households had 5–9 members. Similarly, more than half of the sampled households had household heads who had attained primary school as the highest level of education, and more than 70% (74/104) of the total households were male-headed. In addition, 80% (83/104) of the households had a shared water source between humans and animals (Table 1).

Table 1. Characteristics of the households studied.

Factors Level Frequency (n = 104) Percentage (%)
Sub county of Wakiso district Kakiri 35 33.7
Kasangati 25 24.0
Kasanje 27 26.0
Kyengera 17 16.4
Household size Below 5 21 20.2
5–9 65 62.5
Sex of head Female 30 28.9
Male 74 71.1
Highest education level of household head Primary and below 57 54.8
Secondary 26 25.0
Tertiary and above 21 20.2
Form of location of the household Rural 54 52.0
Urban 50 48.0
Main water source for the household Open 23 22.1
Protected 81 77.9
Commonly shared water source between humans and animals No 21 20.2
Yes 83 79.8
Availability of hand washing facility No 60 57.7
Yes 44 42.3
Use animal waste in gardens No 15 14.4
Yes 89 85.6
Use human fecal in gardens No 90 86.5
Yes 14 13.5
Use human drugs to treat animals No 81 77.9
Yes 23 22.1
Availability of waste dumpsite No 65 62.5
Yes 39 37.5
Drinking water container has lid No 45 43.3
Yes 59 56.7

Characteristics of human and animal participants in the study

A total of 196 participants were involved in this study. About 50% (97/196) of the study participants were aged below 18 years whereas just 10% (19/196) were aged between 18–35 years. Over 57% (113/196) of the participants were females. Additionally, 31.6% (62/196) of the participants were farmers. About 32% (63/196) and 20.9% (41/196) of the participants had previously experienced gastrointestinal and urinal related illnesses respectively. Samples were collected from a total of 393 animals in our study. Compared to other animals, samples were mostly collected from shoats (sheep and goats) 25.0% (99/393). Intensive animal husbandry was the predominant form of animal husbandry, 37.0% (145/393). More than 80% (321/393) of the animals were reported to be treated by a veterinarian (Table 2).

Table 2. Characteristics of human participants and animal subjects.

Factors Level Frequency (n = 196) Percentage (%)
Human participants
Age Less than 18 97 49.5
18–35 19 9.7
Over 35 80 40.8
Sex Female 113 57.7
Male 83 42.3
Education level Formal 160 81.6
None 36 18.4
Occupation Farmer 62 31.6
None 28 14.3
Others 26 13.3
Student 80 40.8
Common condition you suffer from Intestinal 63 32.1
Urinal 41 20.9
None 92 46.9
Sometimes did not complete treatment No 98 50.0
Yes 98 50.0
Often closely interacted with animals No 32 16.5
Yes 162 83.5
Animal subjects (n = 393)
Species aShoats 99 25.2
bPoultry 92 23.4
cCompanion animals 66 16.8
Pig 78 19.8
Cattle 58 14.8
Husbandry practice Backyard 110 28.0
Free range 138 35.1
Intensive 145 36.9
Feeding strategy Kitchen leftover 89 22.7
Natural feeds (grass) 254 64.6
Supplementary feeds (mixed) 50 12.7
Source of water for animals Protected 276 70.2
Unprotected 117 29.8
Treatment options Experienced farmer 5 1.3
Owner treated 67 17.1
Veterinarian 321 81.7

aShoats

bPoultry meant turkey, chicken, and ducks

cCompanion animals included: rabbits, cats and dogs

Burden (prevalence and severity) of ESBL-Ec among households in Wakiso district

More than 80.0% (86/104) of the households had at least one positive sample. Approximately 62.0% (64/104) of the sampled households were found to have humans carrying ESBL-Ec. Over 70.0% (77/104) of the sampled households had animals carrying ESBL-Ec. When assessed at sample level, the overall prevalence of ESBL-Ec at the human-animal-environment interface among samples in Wakiso district was approximately 25.0% (251/988). At individual level, the humans, animals, and environment had ESBL-Ec prevalence of 35.4%, 55.4%, and 9.2% respectively. Approximately 17.0% (18/104) of the sampled households had no positive ESBL-Ec samples and were therefore considered to be low risk. A similar number of households however presented with a high burden implying that all the three sampled components were found to be positive for ESBL-Ec. Approximately 26.0% (27/104) of the households sampled had one of the components being positive (Table 3, Fig 3).

Table 3. Burden of ESBL-Ec among households in Wakiso district.

Component Level Frequency Percentage (95% CI)
Prevalence of ESBL-Ec by household
Overall household (N = 104) 86 82.7 (73.8–89.2)
Humans 64 61.5 (51.5–70.8)
Urine 29 27.9 (19.8–37.7)
Fecal 55 52.9 (42.9–62.7)
Animals 77 74.0 (64.4–81.9)
Environment 21 20.2 (13.2–29.4)
Prevalence of ESBL-Ec by Individual samples
Overall 251 25.4 (22.7–28.3)
Human 89 35.4 (30.7–40.3)
Animals 139 55.4(50.0–61.6)
Environment 23 9.2(6.0–13.6)
Severity of the ESBL-Ec infection among households
No threat 18 17.3 (10.8–26.2)
Low burden 27 26.0 (18.1–35.6)
Medium burden 41 39.4(30.1–49.5)
High burden 18 17.3(10.8–26.2)

Fig 3. Household sharing of ESBL-Ec bacteria.

Fig 3

Distribution of ESBL-Ec positivity among households

Fig 3 shows the different counts of households with the respective components. Majority of the positive households 45.3% (39/86) had both human and animal samples positive but not environment samples. Scenarios with only one component being positive yielded fewer representative households in the order (Animal>Human>Environment). A total of 17 households had their human, animal and environment samples positive for ESBL-Ec (Fig 3).

Factors associated with ESBL-Ec human carriage and household contamination

Several factors (recent visitors, source of water, use of protective lid for water, etc) were associated with ESBL-Ec human carriage among the study population. Notably, households that had received a visitor in the previous 24 hours before sample collection had a higher human ESBL PE carriage (adj PR = 1.34, 95% CI: 1.13–1.60) compared to those that didn’t have a visitor. The prevalence of ESBL-Ec was lower among those that collected water from protected water sources such as taps, protected springs compared to those that collected water from unprotected water sources such as wells (adj PR = 0.63, 95%CI: 0.46–0.88). Participants in households where the drinking water was stored from a container with a lid had a lower prevalence of ESBL-Ec (adj PR = 0.84 95% CI: 0.73–0.96), in addition, households whose environment was found with dirt also had a lower burden of ESBL-Ec among humans (adj PR = 0.71 95%CI: 0.53–0.96) compared to the households with clean environments. We found out that households that had a visitor in the previous 24 hours preceding sample collection were associated with high ESBL-Ec household contamination (adj PR = 1.19, 95% CI: 1.04–1.36) compared to those that had no visitors. Notably, households that used veterinary workers to administer drugs to their sick animals were significantly associated with a higher ESBL-Ec contamination in households (adj PR = 1.39, 95% CI: 1.20–1.61) and, those that used animal waste were more likely to be contaminated with ESBL-Ec (adj PR = 1.29, 95% CI: 1.05–1.60). Additionally, households that reported getting medicines from health workers were more likely to be contaminated with ESBL-Ec (adj PR = 1.39, 95% CI: 1.20–1.61) compared to those that reported engaging in other sources such as friends, self-medication, relatives among others (Table 4).

Table 4. Factors associated with ESBL-Ec human carriage and household contamination.

Variable Level Un adjusted PR (95% CI) adjusted PR (95% CI) p-value
Factors associated with human ESBL-Ec carriage
Household that had a visitor in the last 24 hours No 1 Ref
Yes 0.92(0.81–1.03) 1.34(1.13–1.60) 0.0009***
Protected Water source used as the main water source No 1 Ref
Yes **0.85(0.76–0.95) 0.63(0.46–0.88) 0.006**
Presence of a hand washing facility at home No 1 Ref
Yes *0.86(0.76–0.97) 1.21(0.91–1.62) 0.19
Drugs administered to sick animals by a veterinary-personnel No 1 Ref
Yes **1.39(1.13–1.71) 1.10(0.85–1.39) 0.48
Guidance on how long to wait after treating animal provided by veterinary personnel No 1 Ref
Yes 1.08(0.96–1.23) 0.84(0.70–1.01) 0.068
Household compound found dirty No 1 Ref
Yes 0.93(0.83–1.05) 0.71(0.53–0.96) 0.024*
Presence of stagnant water No 1 Ref
Yes *0.88(0.76–1.00) 0.93(0.70–1.23) 0.59
Drinking water container with lid No 1 Ref
Yes *0.87(0.78–0.98) 0.84(0.73–0.96) 0.014*
Factors associated with ESBL-Ec household contamination
Household had a visitor in the last 24 hours No 1 1 Ref
Yes 0.95(0.88–1.04) 1.19(1.04–1.36) 0.009**
Presence of household member who had been to another district or country in the past one month No 1 1 Ref
Yes *1.08(1.01–1.16) 1.11(0.94–1.30) 0.23
Source of drugs Nonprofessional 1 1 Ref
Professional *1.15(0.99–1.33) 1.39(1.20–1.61) <0.05***
Reasons for negotiating on treatment Financial 1 1 Ref
Side effects 1.09(0.97–1.23) 1.09(1.00–1.19) 0.06.
Cleaning of animal house Twice a week 1 1 Ref
Once a week *1.10(1.00–1.19) 1.06(0.95–1.18) 0.25
Throughout a week 0.97(0.87–1.07) 0.95(0.84–1.07) 0.41
Management of animal waste Dispose 1 1 Ref
Use 1.11(0.96–1.29) 1.29(1.05–1.60) 0.02*
Drugs administered to sick animals by veterinary personnel No 1 1 Ref
Yes *1.28(1.05–1.58) 1.39(1.20–1.61) <0.05**

Discussion

The burden of ESBL-Ec carriage among apparently healthy individuals and animals has been reported to be high globally with limited evidence on the environment [26]. There is scanty information about the ESBL-Ec among humans, animals and their immediate environment especially in LMICs such as Uganda. Surveillance of ESBL-Ec “globally recognized sentinel organism for AMR” at the human-animal-environment interface provides information required to design sustainable one health interventions globally. In our study, we report a high household ESBL-Ec burden. Our findings showed that two factors: visit by animal health workers and visitation to a human health facility were highly associated with human ESBL-Ec carriage and household contamination. These two results are indicative of the poor infection prevention and control measures by both the human and animal health workers thus presenting a great concern for public health.

This study reports an overall ESBL-Ec prevalence of 25.4% from all the components sampled (i.e. humans, animals and environment). On the contrary, authors in Nepal reported 53.4% prevalence of ESBL-Ec at the human-animal-environment interface [10]. This difference could potentially be attributed to the variation in environmental sampling in the two studies. The earlier study considered community drainage and sewage systems around households which overestimated the ESBL-Ec prevalence at household level while this study utilized the immediate household environment that yielded a comparatively low ESBL-Ec. Over 83% of the sampled households had a positive ESBL-Ec sample irrespective of its source. Such findings reveal a high level of household contamination and risk of ESBL-Ec infections especially in a typical farming community. In case of an infection and disease, this situation will certainly drive the cost of treatment high, long stay in the hospitals and could compromise quality of health outcomes for both humans and animals [27].

Majority of the households had animal samples contributing highest to ESBL-Ec household positivity followed by human samples. This result could be attributed to the fact that E. coli is a harmless inhabitant of the human and animal guts [28] apart from its key role in the transmission of ESBL genes. The regular and irrational use of antimicrobials in animal production could also trigger the development of ESBL-Ec in animals [29]. Several human related factors such as self-medication, over the counter medicines, animal food products containing drug residues and the general transmission dynamics of the organisms could explain the observed burden among humans [8]. Perhaps the low contribution to environment ESBL-Ec prevalence is because the environment subjects the bacteria to harsh conditions and therefore their population is constantly being checked [30]. Studies that have documented a high burden of ESBL-Ec in the environment have sampled the sites with constant supply of nutrients for the survival of the organisms such as storm water drains and sewerage systems [31]. Our study utilized the immediate environment of humans and animals to get a clear indicator of transmission dynamics of ESBL-Ec at household level. It is therefore important that future studies focus on the survival and viability of ESBL-Ec in environmental components exposed to harsh weather conditions such as sunshine and heavy rainfall. Households that had a visitor in the previous 24 hours before sample collection had a higher ESBL-Ec contamination compared to those that never had a visitor. Interestingly, also humans from households that had a visitor 24 hours preceding sample collection registered a high ESBL-Ec carriage. Indeed, visitors have been earlier implicated in not only ESBL-Ec occurrence but also the general AMR transmission cycle [32, 33]. This could potentially be attributed to the fact that visitors come from different locations, use different transport means and might be carrying resistant organisms such as ESBL-Ec. Infection prevention and control strategies such as hand washing with soap and sanitizing should be emphasized at household level at all critical hand washing times including when an individual just arrives home as has been promoted in the control of the spread of the COVID-19 pandemic.

Important to note, obtaining water from a protected source was associated with a low ESBL-Ec carriage among humans. Protected water sources provide wholesome water free form contamination by humans, animals, and storm water [34]. Unprotected water sources are vulnerable to a wide range of contamination including ESBL-Ec from the environment and anthropogenic activities [35]. In line with the safe water chain, our study revealed that having drinking water containers covered with lids was associated to low ESBL-Ec human carriage. Safe water storage reduces the bacterial load and further contamination is prevented by covering the storage container with a lid [36]. This is similar to a finding by Brick et al who reported that covering drinking water container with a lid limited contamination [37]. Therefore, there is need for communities to ensure a safe water chain from the water source up to use.

Interestingly, humans from households with compounds having dirt were found to have less ESBL-Ec carriage. A study conducted on improving surface sampling and detection of contamination presents different views and contentions around dirty environments and safety [38]. This could be due to several factors such as use of personal protective equipment (PPE), low survival of ESBL-Ec in the harsh environment, proper personal hygiene practices, among others in farming communities. Several studies have indicated that good hygienic practices, increased household use of PPE and low abundance of bacterial pathogens in the environment could potentially lead to reduced contamination especially with ESBL-Ec organisms [30, 39]. Therefore, more environmental studies are required on bacterial abundance and AMR especially in household environments.

The households that got the drugs from the professional healthcare providers were more likely to be contaminated with ESBL-Ec. Given the high burden of drug resistant organisms, household members who attend or seek medical attention from health care facilities were at higher risk of contracting ESBL-Ec and other nosocomial infections [40]. Humans have ability to shed the contracted bacteria into the environment and or with the animals with in the household setting [8]. Therefore, it is important to improve the infection prevention and control in the health facilities to minimize hospital acquired infections among community members.

Households that contacted a veterinary worker to administer the drugs to their sick animal were more likely to be at risk of ESBL-Ec contamination. Poor on farm biosafety measures, improper compliance to the use of PPE, reuse of veterinary equipment among farms, poor storage of veterinary drugs among others could potentially contribute to the reported household contamination by veterinary workers [41]. In addition, misuse of veterinary products without prior diagnosis could escalate resistance among animals in households [42]. Therefore, improved farm biosafety measures, good veterinary practices as well as veterinary drug use regulations are paramount to reverse the problem of AMR.

Households that used the animal waste in several activities such as gardening, biogas production were more likely to be contaminated with ESBL-Ec than those that disposed of the waste. Studies have indicated the presence of ESBL-Ec in animal waste [39]. Utilization of such waste without decreasing the contamination load and without biosafety precautions exposes the human, other animals and the environment to subsequent ESBL-Ec contamination [43]. Therefore, the use of PPE during waste handling, decontamination of animal waste before use should be emphasized among farming households in order to curb contamination and ESBL-Ec transmission. Our study assessed practices linked to spread and spillover of infectious organisms in a farming household. However, as a limitation, these practices were reported instead of being observed. This limitation was overcome by first creating a good rapport with the respondents to ensure that the responses obtained on practices were as close as possible to the actual practice if it were to be observed. Our study did not characterize the ESBL-Ec organisms genotypically even though a phenotypic analysis was made. Future studies should benefit more from a genotypic characterization of these ESBL-Ec organisms especially at the one health interface.

Conclusion

This study is among the first of its kind in Uganda focusing at determining the ESBL-Ec carriage, contamination, and associated risk factors at household level among farming communities. A wide spread of ESBL-Ec among humans, environment and animals indicates a great public health threat. This observation could potentially be due to poor infection prevention and control (IPC) measures in the area by veterinarians and household members. The role of human, environment, and animal health workers in the occurrence of ESBL-Ec and other types of AMR is therefore critical.

Recommendations

Improved collaborative AMR mitigation strategies such as safe water chain, on farm biosecurity, household, and facility-based IPC measures as well as capacity building of the human, animal and environmental health workers using a one health approach is paramount in order to curb the problem of AMR among farming communities. Veterinarians should be trained in IPC measures and encouraged to disinfect their equipment and sanitize their hands between farms. Further studies in agricultural farmlands need to be done to check for the presence of the beta-lactam drug residues and or actual presence of the ESBL-producing organisms that perhaps could be contaminating the household environments.

Supporting information

S1 File. Letters of support and study approval.

(PDF)

S2 File. Evidence for PhD study.

(PDF)

S1 Data. Dataset.

(XLS)

Acknowledgments

We are grateful to the respondents who participated in this study. We also thank the district and sub county officials who supported the study inception and processes. The local authorities in the respective study sites were very supportive and our research participants in the same regard.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

JM was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No. G-19-57145), Swedish International Development Cooperation Agency (Sida) (Grant No:54100113), Uppsala Monitoring Center, Norwegian Agency for Development Cooperation (Norad), and by the Wellcome Trust [reference no. 107768/Z/15/Z] and the United Kingdom Foreign, Commonwealth & Development Office, with support from the Developing Excellence in Leadership, Training and Science in Africa (DELTAS Africa) programme. In addition, the Climate Change and Infectious Diseases: One Health Approach (CIDIMOH) project under the Norwegian Programme for Capacity Development in Higher Education and Research for Development (NORHED II) supported JM to carry out part of the laboratory component during sample analysis. The statements made and views expressed are solely the responsibility of the Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.O’Nseill J. Review on antimicrobial resistance. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014;2014. [Google Scholar]
  • 2.Jolivet S, Vaillant L, Poncin T, Lolom I, Gaudonnet Y, Rondinaud E, et al. Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital. Clinical Microbiology and Infection. 2018;24: 1311–1314. doi: 10.1016/J.CMI.2018.03.008 [DOI] [PubMed] [Google Scholar]
  • 3.Dembélé R, Konaté A, Traoré O, Kaboré WAD, Soulama I, Kagambèga A, et al. Extended spectrum beta-lactamase and fluoroquinolone resistance genes among Escherichia coli and Salmonella isolates from children with diarrhea, Burkina Faso. BMC Pediatr. 2020;20: 1–9. doi: 10.1186/S12887-020-02342-Z/FIGURES/3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mahmud ZH, Kabir MH, Ali S, Moniruzzaman M, Imran KM, Nafiz TN, et al. Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Drinking Water Samples From a Forcibly Displaced, Densely Populated Community Setting in Bangladesh. Front Public Health. 2020;8: 228. doi: 10.3389/fpubh.2020.00228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Seni J, Mwakyoma AA, Mashuda F, Marando R, Ahmed M, Devinney R, et al. Deciphering risk factors for blood stream infections, bacteria species and antimicrobial resistance profiles among children under five years of age in North-Western Tanzania: A multicentre study in a cascade of referral health care system. BMC Pediatr. 2019;19: 1–11. doi: 10.1186/S12887-019-1411-0/TABLES/6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.R. Martischsang, Surveillance Control, and Management of Resistant Gram-Negative Bacteria in Community and Healthcare Settings. 2022. doi: 10.13097/ARCHIVE-OUVERTE/UNIGE:164827 [DOI] [Google Scholar]
  • 7.Sweileh WM. Global research publications on irrational use of antimicrobials: call for more research to contain antimicrobial resistance. Global Health. 2021;17: 1–12. doi: 10.1186/S12992-021-00754-9/TABLES/3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Nguyen MN, Hoang HTT, Xavier BB, Lammens C, Le HT, Hoang NTB, et al. Prospective One Health genetic surveillance in Vietnam identifies distinct blaCTX-M-harbouring Escherichia coli in food-chain and human-derived samples. Clinical Microbiology and Infection. 2021;27: 1515.e1–1515.e8. doi: 10.1016/j.cmi.2021.01.006 [DOI] [PubMed] [Google Scholar]
  • 9.Martischang R, Riccio ME, Abbas M, Stewardson AJ, Kluytmans JAJW, Harbarth S. Household carriage and acquisition of extended-spectrum β-lactamase–producing Enterobacteriaceae: A systematic review. Infect Control Hosp Epidemiol. 2020;41: 286–294. [DOI] [PubMed] [Google Scholar]
  • 10.Subramanya SH, Bairy I, Metok Y, Baral BP, Gautam D, Nayak N. Detection and characterization of ESBL-producing Enterobacteriaceae from the gut of subsistence farmers, their livestock, and the surrounding environment in rural Nepal. Scientific Reports 2021 11:1. 2021;11: 1–13. doi: 10.1038/s41598-021-81315-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Poirel L, Madec J-Y, Lupo A, Schink A-K, Kieffer N, Nordmann P, et al. Antimicrobial Resistance in Escherichia coli. Microbiol Spectr. 2018;6. doi: 10.1128/MICROBIOLSPEC.ARBA-0026-2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bélanger L, Garenaux A, Harel J, Boulianne M, Nadeau E, Dozois CM. Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. coli. FEMS Immunol Med Microbiol. 2011;62: 1–10. doi: 10.1111/j.1574-695X.2011.00797.x [DOI] [PubMed] [Google Scholar]
  • 13.Li J, Bi Z, Ma S, Chen B, Cai C, He J, et al. Inter-host Transmission of Carbapenemase-Producing Escherichia coli among Humans and Backyard Animals. Environ Health Perspect. 2019;127. doi: 10.1289/EHP5251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Schmitt K, Kuster SP, Zurfluh K, Jud RS, Sykes JE, Stephan R, et al. Transmission Chains of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae at the Companion Animal Veterinary Clinic–Household Interface. Antibiotics 2021, Vol 10, Page 171. 2021;10: 171. doi: 10.3390/antibiotics10020171 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Nchima G, Choongo K, Muzandu K, Nalubamba K, Muma J, Bumbangi F, et al. Determination of oxytetracycline and sulphamethazine residues in marketed beef from selected parts of Zambia to assess compliance with maximum residual limits. Am J Res Commun. 2017;5: 42–64. [Google Scholar]
  • 16.Vannakovida C, Lampang KN, Chuammitri P, Punyapornwithaya V, Kreausukon K, Mektrirat R. Comparative occurrence and antibiogram of extended-spectrum β-lactamase-producing Escherichia coli among post-weaned calves and lactating cows from smallholder dairy farms in a parallel animal husbandry area. Vet World. 2021;14: 1311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kamere N, Garwe ST, Akinwotu OO, Tuck C, Krockow EM, Yadav S, et al. Scoping Review of National Antimicrobial Stewardship Activities in Eight African Countries and Adaptable Recommendations. Antibiotics. 2022;11: 1149. doi: 10.3390/antibiotics11091149 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Nayiga S, Kayendeke M, Nabirye C, Willis LD, Chandler CIR, Staedke SG. Use of antibiotics to treat humans and animals in Uganda: a cross-sectional survey of households and farmers in rural, urban and peri-urban settings. JAC Antimicrob Resist. 2020;2: dlaa082. doi: 10.1093/jacamr/dlaa082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Uganda Bureau of Statistics (UBOS), 2018. Uganda National Household Survey 2016/2017. Kampala, Uganda; UBOS.
  • 20.Uganda Bureau of Statistics (UBOS), 2021. Uganda National Household Survey 2019/2020. Kampala, Uganda; UBOS. [Google Scholar]
  • 21.Uganda Bureau of Statistics (UBOS) and Ministry of Agriculture Animal Industry and Fisheries (MAAIF), National Livestock Census Report, 2008. [Google Scholar]
  • 22.Bennett S, Iiyanagec WM, Smithd D. 5; SIMPLIFIED GENERAL METHOD FOR (CLUSTER-SANllabE SURVEYS OF WEALTH IN DEVELOPING GObfNTIFSfilES. 1991. [PubMed] [Google Scholar]
  • 23.Koltun A, Sobsey MD, Jacob M, Fisher M. EVALUATION OF SIX CHROMOGENIC DIAGNOSTIC CULTURE MEDIA FOR A ONE HEALTH ESBL E. coli INDICATOR SYSTEM FOR GLOBAL AMR SURVEILLANCE. 2018. [Google Scholar]
  • 24.Bubpamala J, Khuntayaporn P, Thirapanmethee K, Montakantikul P, Santanirand P, Chomnawang MT. Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Drug Resist. 2018;11: 2151–2157. doi: 10.2147/IDR.S174506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Silago V, Kovacs D, Samson H, Seni J, Matthews L, Oravcová K, et al. Existence of multiple ESBL genes among phenotypically confirmed ESBL producing Klebsiella pneumoniae and Escherichia coli concurrently isolated from clinical, colonization and contamination samples from neonatal units at Bugando Medical Center, Mwanza, Ta. Antibiotics. 2021;10: 476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Olowe OA, Adewumi O, Odewale G, Ojurongbe O, Adefioye OJ. Phenotypic and molecular characterisation of extended-spectrum beta-lactamase producing Escherichia coli obtained from animal fecal samples in Ado Ekiti, Nigeria. J Environ Public Health. 2015;2015. doi: 10.1155/2015/497980 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, et al. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study. Journal of Infection. 2015;71: 667–674. doi: 10.1016/j.jinf.2015.08.012 [DOI] [PubMed] [Google Scholar]
  • 28.Martinson JN V, Walk ST. Escherichia coli residency in the gut of healthy human adults. EcoSal Plus. 2020;9. doi: 10.1128/ecosalplus.ESP-0003-2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Alyamani EJ, Khiyami AM, Booq RY, Majrashi MA, Bahwerth FS, Rechkina E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann Clin Microbiol Antimicrob. 2017;16: 1. doi: 10.1186/s12941-016-0177-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Waseem H, Williams MR, Stedtfeld RD, Hashsham SA. Antimicrobial resistance in the environment. Water Environment Research. 2017;89: 921–941. doi: 10.2175/106143017X15023776270179 [DOI] [PubMed] [Google Scholar]
  • 31.Buckerfield SJ, Quilliam RS, Bussiere L, Waldron S, Naylor LA, Li S, et al. Detection of enteric viruses and bacterial indicators in a sewage treatment center and Shallow Water Bay. Int J Environ Res Public Health. 2020;744: 6483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Muzembo BA, Kitahara K, Ohno A, Okamoto K, Miyoshi SI. Colonization with extended-spectrum beta-lactamase-producing Escherichia coli and traveler’s diarrhea attack rates among travelers to India: a systematic review and meta-analysis. Trop Dis Travel Med Vaccines. 2022;8: 1–13. doi: 10.1186/S40794-022-00179-1/FIGURES/3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kantele A, Lääveri T, Mero S, Häkkinen IMK, Kirveskari J, Johnston BD, et al. Despite Predominance of Uropathogenic/Extraintestinal Pathotypes Among Travel-acquired Extended-spectrum β-Lactamase–producing Escherichia coli, the Most Commonly Associated Clinical Manifestation Is Travelers’ Diarrhea. Clinical Infectious Diseases. 2020;70: 210–218. doi: 10.1093/cid/ciz182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Amar PK. Ensuring safe water in post-chemical, biological, radiological and nuclear emergencies. J Pharm Bioallied Sci. 2010;2: 253. doi: 10.4103/0975-7406.68508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Krithiga T, Sathish S, Renita AA, Prabu D, Lokesh S, Geetha R, et al. Persistent organic pollutants in water resources: Fate, occurrence, characterization and risk analysis. Science of The Total Environment. 2022; 154808. doi: 10.1016/j.scitotenv.2022.154808 [DOI] [PubMed] [Google Scholar]
  • 36.Ssemugabo C, Wafula ST, Ndejjo R, Oporia F, Osuret J, Musoke D, et al. Knowledge and practices of households on safe water chain maintenance in a slum community in Kampala City, Uganda. Environ Health Prev Med. 2019;24: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Brick T, Primrose B, Chandrasekhar R, Roy S, Muliyil J, Kang G. Water contamination in urban south India: household storage practices and their implications for water safety and enteric infections. Int J Hyg Environ Health. 2004;207: 473–480. doi: 10.1078/1438-4639-00318 [DOI] [PubMed] [Google Scholar]
  • 38.Griffith C. Improving surface sampling and detection of contamination. Handbook of hygiene control in the food industry. Elsevier; 2005. pp. 588–618. [Google Scholar]
  • 39.Salinas L, Loayza F, Cárdenas P, Saraiva C, Johnson TJ, Amato H, et al. Environmental Spread of Extended Spectrum Beta-Lactamase (ESBL) Producing Escherichia coli and ESBL Genes among Children and Domestic Animals in Ecuador. Environ Health Perspect. 2021;129: 27007. doi: 10.1289/EHP7729 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Urase T, Okazaki M, Tsutsui H. Prevalence of ESBL-producing Escherichia coli and carbapenem-resistant Enterobacteriaceae in treated wastewater: a comparison with nosocomial infection surveillance. J Water Health. 2020;18: 899–910. doi: 10.2166/wh.2020.014 [DOI] [PubMed] [Google Scholar]
  • 41.Royden A, Ormandy E, Pinchbeck G, Pascoe B, Hitchings MD, Sheppard SK, et al. Prevalence of faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in veterinary hospital staff and students. Vet Rec Open. 2019;6: e000307. doi: 10.1136/VETRECO-2018-000307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Moreno MA, Collineau L, Carson CA. Antimicrobial Usage in Companion and Food Animals: Methods, Surveys and Relationships With Antimicrobial Resistance in Animals and Humans. Front Vet Sci. 2020;7: 63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Dohmen W, Schmitt H, Bonten M, Heederik D. Air exposure as a possible route for ESBL in pig farmers. Environ Res. 2017;155: 359–364. doi: 10.1016/j.envres.2017.03.002 [DOI] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001344.r001

Decision Letter 0

Ismail Ayoade Odetokun

5 Jan 2023

PGPH-D-22-01776

Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in Wakiso district, Uganda

PLOS Global Public Health

Dear Dr. Muleme,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 19 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ismail Ayoade Odetokun, DVM, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published.

a. State the initials, alongside each funding source, of each author to receive each grant.

b. State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c. If any authors received a salary from any of your funders, please state which authors and which funders.

If you did not receive any funding for this study, please simply state: “The authors received no specific funding for this work.”

2. Please provide separate figure files in .tif or .eps format only and remove any figures embedded in your manuscript file. Please also ensure that all files are under our size limit of 10MB.

For more information about figure files please see our guidelines:

https://journals.plos.org/globalpublichealth/s/figures 

https://journals.plos.org/globalpublichealth/s/figures#loc-file-requirement

3. Your manuscript is missing the following sections: Introduction. Please ensure these are present, and in the correct order, and that any references to subheadings in your main text are correct. An outline of the required sections can be consulted in our submission guidelines here:

https://journals.plos.org/globalpublichealth/s/submission-guidelines#loc-parts-of-a-submission

4. We have noticed that you have uploaded Supporting Information files, but you have not included a list of legends. Please add a full list of legends for your Supporting Information files after the references list. 

5. In the online submission form, you indicated that "Data will be made available upon request". All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons by return email and your exemption request will be escalated to the editor for approval. Your exemption request will be handled independently and will not hold up the peer review process, but will need to be resolved should your manuscript be accepted for publication. One of the Editorial team will then be in touch if there are any issues.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1-Recent references are recommended.

2-Why authors did not use PCR as confirmatory tool for detection of ESBL genes???, phenotypic detection of ESBL strains is not enough.

3-Separation between conclusion and recommendations is necessary.

4-Clear strategies in order to protect human, animal and environment from ESBL are needed.

Reviewer #2: The significance of the One Health concept in the fight against AMR cannot be overstated, thus the significance of this study. It is suggested that authors review the following as stated in the comments:

Line 124- What quality standards were utilized to eliminate obtained samples?

Line 129- Address the multistage sampling strategy referred to as "figure 1" on line 129 is nowhere further included in the text. While "figure 1" on line 170 depicts primary and sub-cultures.

The entire Table and figure labeling should be addressed and corrected. (Lines 264, 265 & 296)

Line 149 & 205- The process of collecting samples needs additional elaboration and explanation. There was a discrepancy between the statement in line 205 that research assistants are responsible for sample collection after receiving proper training and the instruction provided to study participants regarding collection procedures in line 149.

These require clarification for proper comprehension.

Line 160-How were the samples stored before they were processed in the laboratory, and was the processing done as soon as the samples arrived in the laboratory?

Line 242- Were some practice questions administered, observed, or reported by the participants? If they were reported, those should be stated and possibly signified as a limitation of the study since participants were not observed carrying out those practices.

Lines 241 - 242 & 259- Error referencing in results should be clarified.

Lines 271- 273- The sentence should be restructured for ease of understanding and clarity.

Line 296- All tables should be re-formatted, and authors should consider reporting only adjusted PR instead of having unadjusted PR in the table.

To correct all grammatical and spelling errors, the entire manuscript should be reviewed by a native English speaker.

Reviewer #3: Muleme et al., studied the Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in Wakiso district, Uganda.

My comments are as follows:

Abstract

1. Line 38. Replace the word explained and write in past tense. Eg examined

2. Line 48. You cannot have a total of percentage. Rephrase as a total of ** households or write the percentage and remove the “a total of”

3. Line 53. You never mentioned the word “gardening” in the entire manuscript. Kindly check line 387.

Introduction

1. Reference 1 is on Uganda NPHC report. I DO NOT think that report is the correct reference for line 67-69.

2. Line 71. Reference 2 is missing

3. Line 72. Rephrase this statement as: Studies have reported that the resistance to third generation cephalosporins in E. coli ranged from 0–87% whereas resistance to fluoro……..

4. Line 74. Change and colleagues to “et al”

5. Co-carriage with what? Fluoroquinolones?

6. Materials and Methods

Materials and Methods

7. Line 103. Rephrase as: our study “described” and remove “was formulated aiming at”.

8. Line 110. Include “average” before household and include unit such as 4.7 persons.

9. Line 118-127. Could you justify why 260 samples (1248-988) were sub-optimal and did not pass your “thorough quality check”?

10. If your formulae gave you 840 samples, why did you over-sample and collected 1248 out of which 260 were bad and you ended up with 988?

11. Line 129. Change secondary samples to secondary sampling units.

12. Line 143. Is the word recruited appropriate for households?

13. Kindly state that no personal identifying information such as name, phone number or other materials were collected. If they were collected, how did you ensure their protection?

14. Line162. Include the country of the Chromoger.

15. Line 182. Most labs would culture MHA meant for AST at 35 degree and not 37. Kindly confirm this.

Results

16. Line 226. Add “and” before 71.1%

17. Table 1. Factor number 11 and 13 do not add up to 104. Cross-check these.

18. Line 232. How did you arrive at 196 participants? One would assume that 4 individual per household (n=104) would result in 416 human participants “(samples).

19. Line 232. Please remove were recruited to provide samples.

20. Line 236. It would be difficult to separate stomach from intestinal. SO, I would suggest gastrointestinal illnesses rather than intestinal.

21. Line 236. Change “had been commonly suffering” to “have previously experienced”

22. Line 238-239. Kindly include the % in the bracket before the fraction.

23. Line 241-242. Correct the error in the Table.

24. Line 243. Shoat does not mean sheep and goat. Kindly confirm the meeting and edit appropriately.

25. Line 253. Change “up to” to “approximately”

26. Line 259. Revise the highlighted “Error”

27. Line 264. Include Figure number

28. Line 265. Delete Figure from title of table, Delete and households too in Title.

29. Line 277-278 and Line 286-287 appears as a repetition to me. Could you please differentiate these statements?

30. Line 290. Kindly report in past tense. Those that “used” not “using”

31. Line 296. Correct table title.

32. Line 296. Table seems unconvincing. A. Could you tell me what your outcome variable was? B. Was the LR model based on presence of ESBL-PE or absence of ESBL-PE?

C. Could you tell me why a household with dirty environment could have less prevalence than a clean household or why drugs administered by a Vet could have resulted in more ESBL than if it were administered by non-vets?

DISCUSSION

33. Line 316. Change round to around

34. Line 322. Change as well as to “and could compromise…”

35. Line 325. Include “the” before the least contributor.

36. Rephrase line 357. I suggest : “This is similar to the report of Brick et al who reported that …….

37. Your references are not formatted to the Vancouver Standard.

38. Your last reference was 30. However from Line 335, you have continued with 31,32 etc. So, update your reference list and format correctly.

39.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001344.r003

Decision Letter 1

Ismail Ayoade Odetokun

23 Mar 2023

PGPH-D-22-01776R1

Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda

PLOS Global Public Health

Dear Dr. Muleme,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 22 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ismail Ayoade Odetokun, DVM, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Yes

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: We appreciate your efforts to correct all observed comments. However, kindly address the following observations as well.

Line 125- How was cross-contamination avoided if samples from humans, the environment, and animals were kept in the same plastic bag?

Line 154- Explain the process of selecting one individual in a selected household who was requested to provide a fecal and urine sample.

Results section- Tables need to be adequately labeled.

Reviewer #3: You have diligently reviewed the manuscript. Congratulations.

Could you look into the following.

Line 51. As much as possible, dont use the word ”However”. So, delete and start the statement with ””Covering the ....”.

Line 70. A review by ……… cannot have three references. I suggest you change to studies conducted in “xxx country” showed

Line 75. Relationships or interactions?

Line 78 & 79. Italicize E.coli

Line 82. Change since different studies to ….. as different studies have recognized the role of the environment ….. Kindly write in past tense as much as possible

Line 117. Am I right to assume that you wanted to sample 104 households, you got 12 samples from each (total of 1248 and 988 passed your sample screening test). Where does the 840 come from?

Line 118. Delete the “,” after (23)

Line 132. Change approach to technique

Line 149. Rephrase as : mobile based application (kobo Toolbox).

Line 176. The wrong word: incubated. Do you mean : freshly prepared?

Line 180, 193. Use o instead as the 0 is wrong

Line 185. Standard protocols or manufacturer instructions and not standard operating procedures.

Line 242. Remove the bracket on “5-9 members”

Line 154 said : one individual was requested to provide samples per household, Now line 249. You said 196 study participants, How did this come about? Kindly reconcile

Line 257-258, 280, 287 – Typographical error in Table title

Line 255 – You said shoats – 99/393 and in Table pig is 78… you need to reconcile this

Table ****…. ANIMAL SUBJECTS: I think the denominator should be the number of household and not number of animals. Do you think there would be difference in husbandary practice, feeding, source of water, and treatment option per animal belonging to the same household. I think it will make more sense if its based on household and not animals. Instead of 321 animals being treated by a Vet, you state **% of animal owners consulted a vet to treat their animals. What do you think?

Line 260-266. Is repetition of methods and no results therein. Consider deleting it or move to methods. Check Line 123 and 159-160.

Line 269. This was result of analysis of field samples. Why do you need a CI:. You don’t need CI for isolates retrieved from samples.

Line 291. AN opening statement would make it easier to read. Something like: several factors (recent visitors, source of water, use of protective lid for water, etc) were associated withESBL-PE human carriage among the study population.

Line 291-293 Contrdicts line 299-301. Why the results (OR and 95% CI) different?

Line 317. Please remove “the” before LMICs

Line 320. Rephrase the statement to begin as: “Our findings showed that two factors: visit by animal health workers and visitation to a human health facility were highly associated……. “

Line 353-356. Looks like repetition despite the differences: sample collection and data collection. That then raises the question why did you collect them on different days? I suggest you delete one to save you some stress.

Line 362. Am i correct that COVID19 or COVID-19 is the most common way of writing

Line 375. Since you mentioned the study... you should state the different views and contentions as argued by that study.

Line 387. Kindly rephrase as: ... were at higher risk of contracting ESBL-PE and other nosocomial infections (41).

Am happy to recommend the manuscript if these observations have been addressed.

Best wishes

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001344.r005

Decision Letter 2

Ismail Ayoade Odetokun

17 Apr 2023

PGPH-D-22-01776R2

Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda

PLOS Global Public Health

Dear Dr. Muleme,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 17 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ismail Ayoade Odetokun, DVM, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Please pay attention to the minor comments from the reviewers.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Partly

Reviewer #3: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Thank you for the great improvement and work done thus far.

However, kindly pay attention and modify these few observations.

"Line 107" - Provide a reference to the statement made about Wakiso district.

"Line 132" - Reference this ((www.random.org?)) appropriately according to the publication criteria.

"Line 137" - Clarify from which study participants (humans or animals) were you checking for the history of diarrhea episodes and specify how you ascertained the information.

"Line 225, 271, 280, 303" - Clarify the error response feedback (Error! Reference source not found.).throughout the paper.

"Line 272, 304" - Clarify the table error response (Table Error! Reference source not found), found throughout the manuscript.

Reviewer #3: 1, Line 298 and 301still lokks like repetition. It might be scientifically correct but same aOR looks odd.

2. Except for table 1,All table titles (and the line before it) have not be correctly written. –Contains the word *Error* - probably the author doesn’t see this and we only seeit during conversion to pdf

Reviewer #4: Please edit every aspect of the manuscript where the words "source file not found" are appearing.

Though the authors have addressed the majority of the previous comments raised, I still feel strongly that there is a need for the limitation associated with this study be presented just before the conclusion. For instance, the authors did not characterize the ESBL isolates using molecular tools that would allow for adequate discrimination of the strains. This limitation, among others should be discussed.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

Reviewer #4: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001344.r007

Decision Letter 3

Ismail Ayoade Odetokun

2 May 2023

Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda

PGPH-D-22-01776R3

Dear Mr Muleme,

We are pleased to inform you that your manuscript 'Epidemiology of Extended-spectrum beta-lactamase-producing Escherichia coli at the human-animal-environment interface in a farming community of central Uganda' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Ismail Ayoade Odetokun, DVM, Ph.D.

Academic Editor

PLOS Global Public Health

***********************************************************

Please attend to the editing errors noticed by the reviewers.

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Letters of support and study approval.

    (PDF)

    S2 File. Evidence for PhD study.

    (PDF)

    S1 Data. Dataset.

    (XLS)

    Attachment

    Submitted filename: Response to reviewers.pdf

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers comments.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES